Neuroinvasive disease and west nile virus infection, North Dakota, USA, 1999-2008

Emerging Infectious Diseases

Volumn 18, Issue 4, 2012, Pages 684-686

  Carson, Paul J ^a,b   Borchardt, Stephanie M ^a,c,d   Custer, Brian ^e   Prince, Harry E ^f   Dunn Williams, Joan ^g   Winkelman, Valerie ^g   Tobler, Leslie ^e   Biggerstaff, Brad J ^h   Lanciotti, Robert ^h   Petersen, Lyle R ^h   Busch, Michael P ^e,i  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b SANFORD HEALTH   (United States)

^c Fargo VA Medical Center   (United States)

^d WISCONSIN DEPARTMENT OF HEALTH SERVICES   (United States)

^e BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^f Focus Diagnostics   (United States)

^g CREATIVE TESTING SOLUTIONS   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; RISK; SEROPREVALENCE; VIRUS NEUTRALIZATION; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HUMANS; INCIDENCE; MALE; MENINGITIS, VIRAL; MIDDLE AGED; NORTH DAKOTA; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; WEST NILE FEVER; WEST NILE VIRUS; YOUNG ADULT;

EID: 84858629923     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1804.111313     Document Type: Article

References (15)

1. Nash D, Mostashari F, Fine A, Miller J, O'Leary D, Murray K, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med. 2001;344:1807-14. http://dx.doi.org/10.1056/NEJM200106143442401
2. Petersen LR, Hayes EB. Westward ho?-The spread of West Nile virus. N Engl J Med. 2004;351:2257-9. http://dx.doi.org/10.1056/NEJMp048261
3. Lindsey NP, Staples JE, Lehman JA, Fischer M. Surveillance for human West Nile virus disease-United States, 1999-2008. MMWR Surveill Summ. 2010;59:1-17.
4. Zou S, Foster GA, Dodd RY, Petersen LR, Stramer SL. West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis. 2010;202:1354-61. http://dx.doi.org/10.1086/656602
5. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, Cooper MJ, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001;358:261-4. http://dx.doi.org/10.1016/S0140-6736(01)05480-0
6. Lindsey NP, Kuhn S, Campbell GL, Hayes EB. West Nile virus neuroinvasive disease incidence in the United States, 2002-2006. Vector Borne Zoonotic Dis. 2008;8:35-40. http://dx.doi.org/10.1089/vbz.2007.0137
7. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, et al. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis. 2006;12:395-402. http://dx.doi.org/10.3201/eid1203.051287
8. Hogrefe WR, Moore R, Lape-Nixon M, Wagner M, Prince HE. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirusspecific antibodies. J Clin Microbiol. 2004;42:4641-8. http://dx.doi.org/10.1128/JCM.42.10.4641-4648.2004
9. Oceguera LF III, Patiris PJ, Chiles RE, Busch MP, Tobler LH, Hanson CV. Flavivirus serology by Western blot analysis. Am J Trop Med Hyg. 2007;77:159-63.
10. Mandalakas AM, Kippes C, Sedransk J, Kile JR, Garg A, McLeod J, et al. West Nile virus epidemic, northeast Ohio, 2002. Emerg Infect Dis. 2005;11:1774-7. http://dx.doi.org/10.3201/eid1111.040933
11. Meyer TE, Bull LM, Cain Holmes K, Pascua RF, Travassos da Rosa A, Gutierrez CR, et al. West Nile virus infection among the homeless, Houston, Texas. Emerg Infect Dis. 2007;13:1500-3.
12. Schweitzer BK, Kramer WL, Sambol AR, Meza JL, Hinrichs SH, Iwen PC. Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic. Clin Vaccine Immunol. 2006;13:314-8. http://dx.doi.org/10.1128/CVI.13.3.314-318.2006
13. Schellenberg TL, Anderson ME, Drebot MA, Vooght MT, Findlater AR, Curry PS, et al. Seroprevalence of West Nile virus in Saskatchewan's Five Hills Health Region, 2003. Can J Public Health. 2006;97:369-73.
14. Murphy TD, Grandpre J, Novick SL, Seys SA, Harris RW, Musgrave K. West Nile virus infection among health-fair participants, Wyoming 2003: assessment of symptoms and risk factors. Vector Borne Zoonotic Dis. 2005;5:246-51. http://dx.doi.org/10.1089/vbz.2005.5.246
15. Michaels SR, Balsamo GA, Kukreja M, Anderson C, Straif-Bourgeois S, Talati G, et al. Surveillance for West Nile virus cases in Louisiana 2001-2004. J La State Med Soc. 2005;157:269-72.